XEN-101

DRUG2 trials

Sponsors

Xeno Biosciences

Conditions

HealthyObesity

Phase 1

A Phase 1 Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of XEN-101

CompletedNCT05667129

Xeno BiosciencesHealthy

Start: 2022-12-01End: 2023-05-30Updated: 2023-07-20

A Phase 1b Study to Evaluate the Safety of XEN-101

TerminatedNCT06417697

Xeno BiosciencesObesity

Start: 2024-05-24End: 2024-09-09Updated: 2024-09-24